Qatar Health Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Clinical Trials
• Forums

Randomised Open Label Study of Insulin Degludec Versus Insulin Glargine U100 in Ramadan
Condition:   Type2 Diabetes Interventions:   Drug: Insulin Degludec U100;   Drug: Insulin Glargine Sponsors:   Weill Cornell Medical College in Qatar;   Novo Nordisk A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2017 Category: Research Source Type: clinical trials